Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you. Insiders will never let this go up. See recent form 4 from CFO insiders selling at this level because they believe this company is over priced for what it’s producing. Zero value to shareholders
State is not the fed. States abide by the feds
It went to $63 cuz of Reddit bag holders lol
Wow the idiots have come out of the wood work hahaha.
Sure, do I get to choose from an assortment of stuffed animals and or cupie dolls?
Did you not read the part about US Banks being able to get involved lol. That’s the golden ticket. Thanks for playing.
The very fact that states have legalized Cannabis goes against your theory.
You say "IMO waiting for the US to legalize is the dumbest thing I’ve heard. The feds will never allow it . Not in a million years. They banned it because it turned their population against war. Americans love war, it’s the only way they know how to get oil. IMO"
Yet just on rumor when the Democrats won the last election this went from 3 to 63 per share in a heart beat. Once this is decriminalize and US Banks can get invoiced this will be 100 plus dollar stock. Its only a matter of time............
Market cap of 2.6 billion and company is loosing 150m every three months.
No sales are coming thru as the Canadian weed retailers are barely selling products as is .
The Canadian weed experiment was a fail
As the legal weed doesn’t get seasoned smokers high. Just gives them a sore throat because of how harsh it is.
The new people smoking sure they’ll get high but they don’t know what that means either so it’s probably placebo
IMO waiting for the US to legalize is the dumbest thing I’ve heard. The feds will never allow it . Not in a million years. They banned it because it turned their population against war. Americans love war, it’s the only way they know how to get oil. IMO
and it didn't pull back... TLRY
Get your cheap $4 shares while they're still available!
Yup, and it didn't pull back... TLRY
have been holding/adding for too long.
.75 from break even here didn't expect this for months but figured a run was due.
let's see a real squeeze please.
Getting bullish today? Updating your chart Bubbaln? How long Should it stay above four dollars to meet your expectations?
Hope everybody still here managed to get some of the cheap $3 shares from the past month, buckle up for the ride
BULLISH!!
This page goes so quiet when this pops lol. So many wanting in lower. Too bad - chasing time.
Momentum to get us to $300 and beyond.
Beleaguered Cannabis Firm Tilray (TLRY) Finally Gains Momentum
PUBLISHER Fintel
PUBLISHED AUG 5, 2022 8:14AM EDT
Following a torrential implosion of market value since February last year, cannabis firm Tilray (US:TLRY, CA:TLRY) finally gave its stakeholders a reason to smile. Management reported encouraging developments for its fiscal year 2022, including double-digit revenue growth and expectations to be cash flow positive in FY 2023. Further, Switzerland legalizing medical marijuana theoretically expands the total addressable market for cannabis companies. Tilray in particular specializes in exploring the therapeutic potential of the plant.
According to the company’s press release, Tilray posted net revenue of $628 million, representing a 22% lift from the prior year’s tally. On a constant currency basis, net sales increased 29% from FY 2021’s result. In the fiscal fourth quarter (ended May 31, 2022), Tilray generated net revenue of $153 million, up 8% from the year-ago level. Adjusted for currency fluctuations, net revenue increased 14% to $163 million.
Additionally, management expects Tilray to generate $70 million to $80 million of adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) and be free cash flow positive in its operating business units in FY 2023.
Following the above disclosure in the early morning of July 28, TLRY stock gained 12% against the prior day’s session. Over the month between July 5 through Aug. 4, shares have swung higher by more than 24%.
Adding to the optimism for TLRY stock and other cannabis players is a Forbes report that Switzerland legalized medical cannabis starting from Aug. 1. As well, new legislation will allow Swiss companies to export medicinal marijuana for commercial purposes.
In September 2018, Tilray garnered major headlines when it announced a partnership with the University of California, San Diego. Under the arrangement, researchers at the University of California School of Medicine conducted a novel clinical trial to “examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or seizures. Surgery is another option.”
In its FY 2022 disclosure, Tilray stated that it leads the European medical cannabis sector, with 20% market share in Germany. Irwin D. Simon, Tilray Brands’ chairman and CEO, stated “Over the past year, we have accelerated the optimization of our operations and sharpened execution against our most profitable core business opportunities in medical, adult-use, wellness, and beverage-alcohol across Canada, Europe, and the U.S.”
Although investors have many positive details to chew on, Tilray acknowledged that it suffered a net loss of $457.8 million during fiscal Q4 compared to net income of $33.6 million in the prior-year quarter. To explain this dichotomy, Tilray mentioned challenges including “market conditions inclusive of higher rates of borrowing and lower foreign exchange rates.”
The admission of rising borrowing costs comes amid the consumer price index hitting 9.1% over the year ended June 2022. Also, the purchasing power of the dollar declined by 12.92% from the start of the COVID-19 pandemic through June of this year.
By Joshua Enomoto for Fintel
I will be buying as soon as I can scrounge up some extra cheddar.
That seems to be the case - I am holding long term here as one day this will be a 100 plus dollar stock - it is only a matter of time...
Oh it will. People always look for any excuse to sell this stock.
Anyone own CGC - might dip my toe in there this morning on their pull back. I was looking to post on their board but this is not one that seems to be working.
Hope their miss does not hit TLRY.
Sweetwater's brewery is beautiful --->>> 8 Atlanta Breweries To Visit In Celebration of National IPA Day
https://secretatlanta.co/atlanta-breweries-ipa/
Tilray Wellness Announces U.S. Distribution Agreement with Southern Glazer’s Wine & Spirits for CBD Beverages
August 3, 2022 at 7:00 AM EDT
PDF Version
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that Fresh Hemp Foods, Ltd., a part of the Company’s Tilray Wellness division, has signed a distribution agreement with Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the preeminent distributor of wine and spirits. The distribution agreement will provide Tilray Wellness with direct access to Southern Glazer’s distribution network reaching consumers everywhere from local bars and restaurants to independent and national grocery chains and convenience stores.
Jared Simon, President, of Tilray Wellness and Fresh Hemp Foods, said, “This agreement helps Tilray uniquely position itself to enter the multi-billion-dollar adult beverage category with a non-alcoholic, CBD beverage alternative, for consumers who want to relax and unwind.”
As the leading distributor of beverage alcohol and CBD beverages in the U.S., Southern Glazer’s will be the exclusive distribution partner for the Tilray Wellness CBD beverage portfolio across 13 states with additional opportunities to scale nationwide. This strategic agreement will allow Tilray Brands to develop a U.S. CBD beverage portfolio within familiar retail channels, which will transition the category out of the fringe and into the mainstream. Tilray is excited to tap into the industry’s most knowledgeable CBD sales team and be part of their industry-leading Proof® e-commerce platform so retailers have access to its CBD Beverage portfolio 24/7.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and by providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we open a world of wellbeing, visit www.Tilray.com and follow @tilray on all social platforms.
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations concerning, among other things: expectations regarding the performance and scale of the Company, including Tilray Medical; and the Company’s ability to expand its offering to patients worldwide, including via Tilray Medical. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
For further information:
Media
Berrin Noorata
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Tilray Brands, Inc.
Breckenridge Distillery and Denver Broncos Release Limited-Edition Mile High Bourbon Blends
August 4, 2022 at 7:00 AM EDT
America’s Best Blended Whiskey is Back and Better Than Ever
BRECKENRIDGE, Colo., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Breckenridge Distillery, the ‘World’s Highest Distillery’ and the official Bourbon of football franchise, the Denver Broncos, today announced two new limited-edition Mile High Bourbon Blends, the second commemorative Broncos Bourbon Blends of the series collaboration. Fans aged 21 or older can purchase the limited-edition bottles beginning Monday, Aug. 8.
To make the Mile High Blends, Broncos Alumni, Jake Plummer, and Breckenridge, Head Distiller, Hans Stafsholt (Blue), faced off with Broncos ‘Ring of Famer’, Karl Mecklenburg and Breckenridge Distillery, Founder, Bryan Nolt (Orange), to see who can blend the better bourbon. In the Blue Broncos Bourbon Blend, honey crisp apple and fresh orange envelop the nose leading to a creamy orange and orange blossom honey on the palate, finished with oak and light white pepper spice. The Orange Broncos Bourbon Blend invites a burnt orange marmalade and brandied raisin aroma leading to dark brown sugar with a light cherrywood smoke, vanilla, rye spice and a light black pepper finish. Encased in a commemorative orange or blue bottle, these limited-edition bourbon blends pay homage to the Broncos Mile High Era and include the team’s classic 1962 logo on their label.
Breckenridge x Denver Broncos Mile High Blend
The limited-edition Mile High Bourbon Blends from Breckenridge Distillery are made by Broncos Alumni Jake Plummer and Breckenridge Head Distiller Hans Stafsholt (Blue) and Broncos ‘Ring of Famer’, Karl Mecklenburg and Breckenridge Distillery, Founder, Bryan Nolt (Orange). (Photo courtesy: Breckenridge Distillery)
“Last year we released our first collaboration with the Denver Broncos and the Broncos Bourbon blends were not only a hit with our Colorado fans, but the whiskey industry as a whole,” says Nolt. “We’re so excited to continue our partnership with the Broncos and bring Broncos and whiskey fans across the country our latest release of the Mile High Blends to enjoy this season.”
The first collaboration of the series, the Champions Blend, garnered recognition in the whiskey world by being named Best American Blended Whiskey, Limited Release and Campaign Innovator of the Year by Whisky Magazine at the World Whiskies Awards.
To learn more about Breckenridge Distillery and where to buy its award-winning spirits, visit: http://breckenridgedistillery.com/bourbon-of-denver-broncos/.
About Breckenridge Distillery
Founded in 2008, Breckenridge Distillery is the “World’s Highest Distillery” widely known for its award-winning blended bourbon whiskey, a high-rye mash American-style whiskey. As one of the most highly awarded craft bourbons in the U.S., Breckenridge Bourbon is proudly a 3x Icons of Whisky and 5x winner of Best American Blended winner at the World Whiskies Awards by Whisky Magazine and a 4x winner of Colorado Distillery of the Year by the New York International Spirits Competition. Most recently, Breckenridge Gin and PX Sherry Cask Finish Whiskey received Double Gold at the San Francisco World Spirits Competition. In 2021, Breckenridge Gin was named the World’s Best Compound Gin at the World Gin Awards by Gin Magazine.
For more information about Breckenridge Distillery, visit www.breckenridgedistillery.com.
Become a fan and follow @BreckDistillery on Instagram. #BreckDistillery #BroncosBourbon
Breckenridge Distillery was acquired by Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) in December 2021. For more information on Tilray Brands, visit www.Tilray.com and follow @Tilray
Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.
For further information:
Media
Berrin Noorata
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Heinz is the best...
Duder... Cannabis ain,t your cheap ketchup recipe.
If it was, you,d be golden...
Instead of doomed!!!
LOL...
Tell that to Heinz. Any idiot can make ketchup and yet.......
Tlry On the streets $60 ounce killer OG platinum other good strains $40 oz Pretty soon we will be seeing $10 an ounce how do these companies make money? To me all these weed companies are going to go out of business. Weed is worthless if everyone can grow it. In the 70s Pot was worthless $5 oz
I agree, it's nice to see it trending above the 50 day moving avg finally
Looking good here...Bottom is in in my opinion...
'ANYTHING IN THE MID 2 DOLLAR RANGE I WILL LOAD UP HUGE PERIOD'
Might not get the chance my friend, don't miss out on the $3 cheapees while they're still available
I'm selling...................................at $100.
The entire cannabis sector is up because Senator Booker said he is willing to compromise and pass SAFE banking. I hate to be pessimistic but what politicians say and do are often two different things. We have seen that for the last 20 months. I'll believe it when I see it.
Are you traders selling here or holding for higher? I think we just might close above 4 but what the hell do I know.
Amazing how big pharma spins things. Almost every mass shooter has been on big pharma drugs and now they are trying to deflect the blame and pin it on marijuana. How pathetic and low can big pharma go?
cant wait my finger is in the trigger
Simply put. They paid with TLRY shares which are restricted btw for one year so in essence they get a free company because they know their shares will be worthless in a year.
They sell shares to cover operations and they have been losing 3 - 5 million a month
IMO
Followers
|
423
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
16223
|
Created
|
07/16/18
|
Type
|
Free
|
Moderators |
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*DISCLAIMER *The Board Monitor and herewith, are not licensed brokers and assume NO responsibility for the actions,
investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |